Backer, Joseph M <br/><br/>
Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  Nov 2009 
 - 1165-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1593/neo.09878  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Bacterial Toxins--pharmacology<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Drug Synergism<br/>Endoplasmic Reticulum--drug effects<br/>Endoplasmic Reticulum Chaperone BiP<br/>Epidermal Growth Factor--pharmacology<br/>Female<br/>Heat-Shock Proteins--drug effects<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Microscopy, Fluorescence<br/>Neoplasms, Experimental--drug therapy<br/>Prostatic Neoplasms--drug therapy<br/>Protein Folding--drug effects<br/>Recombinant Fusion Proteins--pharmacology<br/>Stress, Physiological--drug effects<br/>Xenograft Model Antitumor Assays